PopVax manufactures personalized mRNA cancer vaccines
RNA Foundry, part of PopVax funded by the Gates Foundation and Vitalik Buterin, secured a contract to develop and manufacture personalized mRNA cancer vaccines in Hyderabad.
- Field
- cancer research
- What they did
- Company PopVax launched production of personalized mRNA cancer vaccines in India, using the same platforms and processes as for its COVID-19 vaccine.
- Why it matters
- This enables creating individual vaccines for each patient based on their specific mutations, which may improve cancer treatment efficacy.
#popvax#rna vaccine#personalized medicine#gates foundation#vitalik buterin#hyderabad



